Bull market in biotechs, the market in general, and RNAI specifically, but TKMR is being left behind. ALNY doubled since settlement. You'd think TKMR lost the law suit.
In some ways, I guess they did. They were hoping for a $1 billion dollar payday.
Sitting just a few million above cash. Unfortunately, that's what happens to small thinly traded biotechs with no near term upside catalysts. Some trial results should be out in a couple of months. May push us back near 5, but don't bet on it.